Sizing up the Pregnancy and Lactation Labeling Rule: Understanding Challenges and Opportunities

The labeling rules governing how medication risks associated with pregnancy and lactation are displayed on product packaging and inserts have been under scrutiny for years. In response to growing concerns among healthcare professionals about the utility of the pregnancy labeling format, the U.S. Food and Drug Administration (FDA) implemented new rules to improve pregnancy safety labeling.

Download White Paper

You may also like:

Blog Post

It may not be exciting or cutting-edge, but the pharmaceutical supply chain and pharmacy profession’s operations are tied to an infrastructure that depends on a 10- or 11-digit number: the

View Blog Post
Blog Post

A recent study found the use of non-steroidal anti-inflammatory drugs (NSAIDs) in combination with oral anticoagulant therapy in patients with atrial fibrillation was associated with an increased risk of major bleeding compared...

View Blog Post
Blog Post

Last week, the U.S. Senate passed its ambitious Opioid Crisis Response Act of 2018 (S.2680) by a vote of 99 to 1. The bill differs...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up